Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New monthly shot keeps anemia in check for kidney patients

NCT ID NCT00661388

First seen Sep 30, 2025 · Last updated Jun 12, 2026 · Updated 32 times

Summary

This study tested a monthly injection called Mircera for people with chronic kidney disease who have anemia (low red blood cells) and are not yet on dialysis. 75 adults received the shot for 3 to 12 months. The goal was to see if it could safely raise and maintain hemoglobin levels. The treatment helped improve anemia, but patients need ongoing medication to manage the condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ANEMIA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Study site

    Ankara, 06100, Turkey (Türkiye)

  • Study site

    Denizli, 20100, Turkey (Türkiye)

  • Study site

    Edirne, 22030, Turkey (Türkiye)

  • Study site

    Istanbul, 34000, Turkey (Türkiye)

  • Study site

    Istanbul, 34377, Turkey (Türkiye)

  • Study site

    Istanbul, 34381, Turkey (Türkiye)

  • Study site

    Istanbul, 34390, Turkey (Türkiye)

  • Study site

    Kahramanmaraş, 46100, Turkey (Türkiye)

  • Study site

    Konya, 42770, Turkey (Türkiye)

Conditions

The condition(s) this trial relates to.

anemia

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.